Latest filingAug 29, 2026Most recent Form 4
MNPR
Monopar Therapeutics
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$161M19 sells
Net open-market-$161M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period29transactions
- S · Open-market sells · dominant19 · 66%
- M · Option exercise10 · 34%
Activity by reported role
A joint filing can contribute to multiple roles29transactions
- Director · dominant26 · 90%
- ACMO3 · 10%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeTsuchimoto Kim RCommon Stock · Direct
2,055Aug 26, 2026
Anderson RaymondCommon Stock · Direct
8,515Aug 25, 2026
Anderson RaymondStock Option · Direct
3,480Aug 25, 2026
Rioux PatriceCommon Stock · Direct
5,065Aug 26, 2026
Tsuchimoto Kim RStock Option · Direct
6,165Aug 26, 2026
Rioux PatriceStock Option · Direct
0Aug 26, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- TR-$365.4k
Recent filing activity
Most recent 10 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
MNPR transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| MNPR | Tsuchimoto Kim R | DIR | exercise10b5-1 | 2.03k | $0 | M | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | exercise10b5-1 | 2.05k | $0 | M | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 590 | -$6.71M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 602 | -$6.79M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 1.09k | -$12.2M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 700 | -$7.74M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 615 | -$6.73M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | sale10b5-1 | 485 | -$5.27M | S | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | exercise10b5-1 | 2.03k | $2.84M | M | 0.0% | 08/29 | 08/26 | |
| MNPR | Tsuchimoto Kim R | DIR | exercise10b5-1 | 2.05k | $6.16M | M | 0.0% | 08/29 | 08/26 |
Monopar Therapeutics Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Monopar Therapeutics?
Tsuchimoto Kim R, Anderson Raymond, RIOUX PATRICE.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Tsuchimoto Kim R reported a sale on Aug 26, 2026 valued at $6.71M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,614,268.88. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.